These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22960339)

  • 1. Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi Syndrome.
    Anichini C; Lotti F; Longini M; Proietti F; Felici C; Perrone S; Buonocore G
    Dis Markers; 2012; 33(4):179-83. PubMed ID: 22960339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beckwith-Wiedemann syndrome: potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk.
    Anichini C; Lo Rizzo C; Longini M; Paoli G; di Bartolo RM; Proietti F; Buonocore G
    Anticancer Res; 2011 Nov; 31(11):3973-6. PubMed ID: 22110229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effects of potassium ascorbate with ribose in costello syndrome.
    Anichini C; Lotti F; Pietrini A; Lo Rizzo C; Longini M; Proietti F; Felici C; Buonocore G
    Anticancer Res; 2013 Feb; 33(2):691-5. PubMed ID: 23393369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report.
    Candler T; McGregor D; Narayan K; Moudiotis C; Burren CP
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):951-955. PubMed ID: 32447330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome.
    Rigamonti AE; Crinò A; Bocchini S; Convertino A; Bidlingmaier M; Haenelt M; Tamini S; Cella SG; Grugni G; Sartorio A
    Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
    Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
    J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatropin therapy in adults with Prader-Willi syndrome.
    Höybye C; Thorén M
    Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment in a girl with Prader Willi syndrome.
    Pandey SN; Vaidya RA; Irani A
    Indian J Pediatr; 2003 Apr; 70(4):351-3. PubMed ID: 12793314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.
    Myers SE; Davis A; Whitman BY; Santiago JV; Landt M
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):101-5. PubMed ID: 10651760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
    Zipf WB
    Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
    Cohen M; Harrington J; Narang I; Hamilton J
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the Prader-Willi syndrome imprinting center on the DNA methylation landscape in the mouse brain.
    Brant JO; Riva A; Resnick JL; Yang TP
    Epigenetics; 2014 Nov; 9(11):1540-56. PubMed ID: 25482058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood.
    Longini M; Belvisi E; Proietti F; Bazzini F; Buonocore G; Perrone S
    Mediators Inflamm; 2017; 2017():1758432. PubMed ID: 28512386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.